Table 1 NPs played their biologic role by inducing ROS burst in cells
From: Reactive Oxygen Species-Related Nanoparticle Toxicity in the Biomedical Field
No. | Type of NPs | Potential applications | ROS | Dose | Molecule mechanism of biotoxicity | References |
---|---|---|---|---|---|---|
1 | Nano-C60 | Antibacterial agents, Anticancer agents. | ↑ | 1 μg/mL | Necrosis, apoptosis, autophagy, DNA fragmentation, cell membrane damage. | |
2 | Carbon-based nanodots | Antibacterial agents. | ↑ | > 1 mg/mL | Oxidize the phospholipids, destroy the membranes. | [29] |
3 | Ag | Antibacterial agents. | ↑ | 150 μg/mL | Intracellular oxidation, membrane potential variation, membrane permeability disruption, DNA damage, genomic instability, cell cycle arrest, cellular contents release, inactivate proteins, autophagy, disturb electron transfer process. | |
4 | Gold-silver nanocage | Antibacterial agents. | ↑ | 2.5 μg/mL | Destruction of cell membrane, apoptosis. | [37] |
5 | ZnO | Wastewater purification, antibacterial agents, antitumor agents, fillers in orthopedic, and dental implants. | ↑ | 20 μg/mL | Disintegration the cell membrane, inhibition enzyme activity, inhibition DNA synthesis, DNA damage, interruption of energy transduction, mitochondrial damage, apoptosis, intracellular outflow, mitotic arrest, carcinogenic. | |
6 | Gold | Anticancer agents, antibacterial agents. | ↑ | 20 μM | Collapse membrane potential, inhibit ATPase activities, inhibit the subunit of ribosome. | |
7 | MgO | Antibacterial agents, anticancer agents. | ↑ | 100 mg/mL | Lipid peroxidation, apoptosis. | |
8 | Fe3O4 | Antibacterial agents. | ↑ | 32 μg/mL | DNA cleavage. | [50] |
9 | CdSe | Antibacterial agents. | ↑ | Inhibition proliferation. | [51] | |
10 | TiO2 | Antimicrobial agents, air and water purification, dental prosthesis. | ↑ | 10 μg/mL | Loss respiratory activity, interfere oxidative phosphorylation, DNA lesions, mitochondrial dysfunction, carcinogenicity. | |
11 | Al2O3 | Antibacterial agents, cross-linker. | ↑ | 0.16 mg/L | DNA damage, mutagenesis. | |
12 | VO2 | Antimicrobial agents. | ↑ | 2.5 μg/mL | Mitochondrial dysfunction apoptosis. | |
13 | V2O5 | Antimicrobial agents. | ↑ | 20 mg/L | Interruption mitochondrial function. | |
14 | PCAE | Antimicrobial agents. | ↑ | 30 μg/mL | Membrane damages. | [64] |
15 | Co-ZnO | Antimicrobial agents. | ↑ | 20 μg/mL | Low toxicity. | [65] |
16 | Hybrid Gold/Polymer | Antimicrobial agents. | Unknown | Unknown | No cytotoxicity. | [66] |
17 | Ag-Fe NPs | Antimicrobial agents. | ↑ | 100 mg/L | LDH release, disruption membrane integrity. | [67] |
18 | Phycocyanin-ZnO nanorod | Protect cell. | ↓ | 50 μg/mL | Decrease in ROS production. | [68] |
19 | Ag/lyz-Mt | Antimicrobial agents, water disinfection. | ↑ | 160 μg/mL | Damage cell membrane. | [69] |
20 | PEGylated ZnO | Antimicrobial agents, biological labeling. | ↑ | 45 ppm | Low cytotoxicity. | [70] |
21 | CdS NPs | Antimicrobial agents. | ↑ | 4 μg/mL | Inhibition proper cell septum formation, change morphology, fragment nuclei. | [71] |
22 | CdTe | Antimicrobial agents. | ↑ | 0.4 mg/L | Morphological damages, apoptosis, genotoxicity. | [72] |
23 | ZnO@APTMS/Cu QDs | Antibacterial agents. | ↑ | 1.4 × 10-4 M | Inhibition proliferation. | [73] |
24 | CuO | Antimicrobial agents. | ↑ | 5 mg/L | Increase cell permeability, lipid peroxidation, DNA damage, morphological alterations, mitochondrial dysfunction, interruption ATP synthesis. | |
25 | Mn3O4 | Antioxidant. | ↓ | 20 ng/μL | Protect biomolecules against ROS. | [77] |
26 | PEGylated nanoceria | Antioxidant. | ↓ | 10 μM | Cell protection, radical scavenger. | [78] |
27 | CeO2 | Against oxidative damage. | ↓ | 2.5 μg/mL | Suppressed ROS production, protect cells, and tissues. | [79] |
28 | AuNPs-rGO-NC | Anticancer agents, antimicrobial agents. | ↑ | 50 μg/mL | Reduction cell activity, | [80] |
29 | CONPs | Anticancer agents. | ↑ | 10 μM | DNA damage. | [81] |
30 | Graphene | Cancer theotherapy, bioimaging, biosensing. | ↑ | 25 μg/mL | DNA damage, mutagenesis. | |
31 | Fe2O3 | Antibacterial agents. | ↑ | 80 μg/mL | DNA damage. | [84] |
32 | NiO | Antibacterial agents. | ↑ | 10 mg/L | DNA damage. | |
33 | PtAuNRs | Anticancer agents. | ↓ | OD at 0.5 | Induce hyperthermia. | [87] |
34 | SWCNTs | Clinical diagnostic agent, bioengineered research. | ↑ | 50 μg/cm2 | DNA damage. | [88] |
35 | bsCdS | Anticancer agents. | ↑ | 15 μg/mL | Apoptosis, depletion ATP, DNA damage. | [89] |
36 | Ag@OTV | Against H1N1 infection. | ↓ | Unknown | Less cytotoxicity. | [90] |
37 | Antibacterial agents. | ↑ | 5.5 μg/mL | Less cytotoxicity. | [91] |